Division of Vascular and Endovascular Surgery, Department of Surgery, University Of Texas Southwestern Medical School, Dallas, TX, USA.
J Vasc Surg. 2011 Oct;54(4):979-84. doi: 10.1016/j.jvs.2011.03.270. Epub 2011 Jun 12.
Left subclavian artery (LSA) coverage during thoracic endovascular aortic repair (TEVAR) is often necessary due to anatomic factors and is performed in to up to 40% of procedures. Despite the frequency of LSA coverage during TEVAR, reported associations with risk of periprocedural stroke or death are inconsistent in reported literature. We examined the 2005-2008 American College of Surgeons National Surgical Quality Improvement Program Participant Use Data file to determine associations between LSA coverage during TEVAR and risk of perioperative stroke or death.
Current procedural terminology (CPT) codes were used to identify patients undergoing TEVAR, LSA coverage, and subclavian revascularization. Patients undergoing coronary bypass, ascending aortic repair, abdominal aortic aneurysm repair, or nonvascular intra-abdominal procedures during the same operation were excluded. Perioperative stroke and mortality associations with LSA coverage were examined using logistic regression models for each outcome. Significance was assessed at α = 0.05, with univariable P < .05 required for multivariable model entry.
Eight hundred forty-five TEVAR procedures were identified, of which 52 patients were excluded due to additional major procedures performed with TEVAR. Seven hundred thirty-three of the remaining 793 procedures included CPT codes indicating primary placement of an initial thoracic endograft and form the basis of this analysis. LSA coverage occurred in 279 procedures (38%). Thirty-day stroke and mortality rates were 5.7% and 7.0%, respectively. LSA coverage was associated with increased 30-day risk of stroke in multivariable modeling (odds ratio [OR], 2.17 95% confidence interval [CI], 1.13-4.14; P = .019). Other significant multivariable risk factors for stroke included proximal aortic cuff placement during TEVAR (OR, 2.58; 95% CI, 1.30-5.16; P = .007) and emergency procedure status (OR, 3.60; 95% CI, 1.87-6.94; P < .001). No significant association between LSA coverage and perioperative mortality was identified (univariable OR, 1.70; 95% CI, 0.98-2.93; P = .0578).
LSA coverage during thoracic endovascular repair is associated with increased risk of perioperative stroke following TEVAR. Further evidence is needed to determine whether procedural modifications, including LSA revascularization, reduce the incidence of stroke associated with TEVAR.
由于解剖因素,在胸主动脉腔内修复术(TEVAR)中经常需要覆盖左锁骨下动脉(LSA),该操作在多达 40%的手术中进行。尽管在 TEVAR 过程中经常覆盖 LSA,但报告的围手术期卒中或死亡风险与 LSA 覆盖之间的相关性在报告的文献中并不一致。我们检查了 2005-2008 年美国外科医师学会国家手术质量改进计划参与者使用数据文件,以确定 TEVAR 过程中 LSA 覆盖与围手术期卒中或死亡风险之间的关联。
使用当前程序术语 (CPT) 代码来确定接受 TEVAR、LSA 覆盖和锁骨下动脉血运重建的患者。排除在同一手术中接受冠状动脉旁路、升主动脉修复、腹主动脉瘤修复或非血管腹腔内手术的患者。使用逻辑回归模型分别检查 LSA 覆盖与围手术期卒中和死亡率的相关性。采用单变量 P <.05 进入多变量模型,以 0.05 为检验水准评估统计学意义。
确定了 845 例 TEVAR 手术,其中 52 例由于与 TEVAR 同时进行的其他主要手术而被排除。在剩余的 793 例中,有 733 例包含表示初次放置胸主动脉腔内移植物的 CPT 代码,这是本分析的基础。在 279 例(38%)中进行了 LSA 覆盖。30 天的卒中发生率和死亡率分别为 5.7%和 7.0%。多变量建模显示 LSA 覆盖与 30 天卒中风险增加相关(比值比 [OR],2.17;95%置信区间 [CI],1.13-4.14;P =.019)。卒中的其他重要多变量危险因素包括 TEVAR 期间近端主动脉袖口放置(OR,2.58;95% CI,1.30-5.16;P =.007)和紧急手术状态(OR,3.60;95% CI,1.87-6.94;P <.001)。未发现 LSA 覆盖与围手术期死亡率之间存在显著相关性(单变量 OR,1.70;95% CI,0.98-2.93;P =.0578)。
胸主动脉腔内修复术中覆盖 LSA 与 TEVAR 后围手术期卒中风险增加相关。需要进一步的证据来确定包括 LSA 血运重建在内的手术方法的改变是否可以降低与 TEVAR 相关的卒中发生率。